PINK1/PARKIN-mediated mitophagy inhibits the interferon response and promotes viral replication during Pseudorabies virus infection Authors: Yuan Zhao, Zhenbang Zhu, Wenqiang Wang, Zhendong Zhang, Wei Wen, Xiangdong Li Published: 2024 ABSTRACT ABSTRACTPseudorabies virus (PRV) poses a significant threat to the global swine industry, characterized by high morbidity and a range of sequelae in infected pigs. Mitochondria serve as a crucial platform for innate immunity, playing a pivotal role in a wide array of antiviral responses. In our recent study, we revealed that PRV infection induces mitochondrial disruption, which in turn triggers PINK1/PARKIN-mediated mitophagy. We also show that this process leads to the degradation of the mitochondrial antiviral signaling protein (MAVS) and the inhibition of antiviral interferon production and signaling, ultimately facilitating viral replication. Mitochondria serve as crucial organelles that respond to viral infections by actively regulating numerous immune signaling. In turn, viruses employ multiple strategies to disrupt mitochondrial physiological processes, including mitochondrial dynamics and mitophagy, to promote its own replication. While several interactions between viruses and mitochondria have been reported, it remains unclear whether pseudorabies virus (PRV) infection may induce and/or utilize mitophagy during viral replication. We found that PRV infection damages to the mitochondrial structure in epithelial cells, since these appeared fragmented and incomplete. Transmission electron microscopy revealed the presence of swollen mitochondria that are deformed and lack the mitochondrial inner membrane and cristae. A significant reduction in mitochondrial membrane potential (MMP) was also observed, along with a disruption in the mitochondrial dynamics characterized by the inhibition of fusion and promotion of fission. Notably, we observed a dramatical decrease in mitochondria number at the late stage of PRV infection, i.e., 18–24 hours post-infection. Therefore, we hypothesized that PRV may induce mitophagy to eliminate damaged mitochondria at late stages of viral infection. To verify this hypothesis, chloroquine (CQ), an inhibitor of lysosomal acidification, was utilized to block the degradation of mitochondria in the lysosomes. The protein levels of mitochondrial marker protein TOM20 (translocase of outer mitochondrial membrane 20) and COX-4 (Cytochrome c oxidase subunit 4) in PRV-infected cells were restored by CQ, indicating that PRV infection induced mitophagy to clear the damaged mitochondria. Moreover, we confirmed that PRV infection induced a complete mitophagic process by showing co-localization of mitochondria with the autophagosomal and lysosomes markers TOM20 and LAMP1 (lysosomal associated membrane protein 1), respectively. Mitophagy is mediated by either selective autophagy receptors present in the outer mitochondrial membrane (OMM) such as BNIP3 (BCL2 interacting protein 3), FUNDC1 (FUN14 domain containing 1), NIX (NIP3-like protein X) and or ubiquitination by the PINK1 (PTEN induced kinase 1)/PARKIN (parkin RBR E3 ubiquitin protein ligase) system and subsequent recognizing by ubiquitin binding selective autophagy receptors. In our recent study, we found that PRV induces mitophagy via the PINK1-PARKIN pathway [1]. In normal conditions, PINK1 protein kinase levels are low due to its proteolytic turnover by mitochondrial protease PARL upon entering the inner mitochondrial membrane. When MMP is depolarized, PINK1 translocation into mitochondria is blocked and it accumulated at the OMM, becoming autophosphorylated at serine 228. This modification is a prerequisite for the recruitment of PARKIN onto damaged mitochondria. Then, PINK1 activates the E3 ligase activity of PARKIN by phosphorylating its serine 65, which in turn phosphorylate several OMM proteins, including MFN2 (mitofusin 2). Finally, ubiquitin-binding selective autophagy receptors such as SQSTM1/p62 (sequestrosome 1), CALCOCO2/NDP52 (calcium binding and coiled-coil domain 2), and OPTN (optineurin) are recruited to the ubiquitinated mitochondria and facilitate the local formation of mitophagosomes. PRV infection not only increased the phosphorylation levels of PINK1 and PARKIN at serine 228 and serine 65, but also increased PARKIN association to mitochondria, ubiquitination of MFN2, as well as localization of ubiquitin-binding selective autophagy receptors to mitochondria, suggesting that PRV infection induced PINK1/PARKIN-dependent mitophagy. Furthermore, we also found that treatment of UV or phosphonoacetic acid, a drug that suppresses viral DNA replication and late viral protein expression, were blocking PRV-induced mitophagy. This observation suggests that the viral genome replication and/or the expression of viral late proteins were prerequisite for the induction of mitophagy. However, it remains unknown which late proteins in the PRV viral cycle are involved in the activation of mitophagy activation remains and their identification will require further investigation. To understand the role of mitophagy in PRV replication, we inhibited mitophagy with mitochondrial division inhibitor 1 (Mdivi-1), which block mitochondria fission and thus mitophagy by inhibiting DRP1(dynamin related protein 1), CQ and PARKIN knockdown. Inhibition of mitophagy resulted in decreased viral protein synthesis and virus titers, suggesting that PRV utilized mitophagy for viral replication. Importantly, the above-described inhibition of mitophagy also resulted in the increased mRNA expression of IFN-β (interferon beta 1), IFIT1 (IFN-stimulated genes tetratricopeptide repeats 1) and ISG15 (ISG15 ubiquitin like modifier). Mitochondrial antiviral signaling protein (MAVS), a key antiviral protein located in the mitochondria, is the hub protein of the RIG-I (RNA sensor RIG-I) signaling pathway that regulates the IFN production. Thus, we hypothesized that PRV-induced mitophagy may cause MAVS degradation and consequently attenuation of the interferon response. We found that PRV infection decreased the levels of MAVS in both whole-cell lysates and in mitochondrial and cytoplasmic lysates. Importantly, inhibition of mitophagy with CQ and Mdivi-1, as well as Parkin knockdown, restored MAVS levels, while proteasome and caspase inhibitors did not. We concluded that PRV infection triggers PINK1/PARKIN-mediated mitophagy to promote MAVS degradation, which results in the inhibition of IFN-I production and enhances viral replication (Figure 1). Figure 1.PRV infection induces mitophagy to inhibit IFN-I signaling to enhance its own replication. PRV infection damages the structure and function of mitochondria by disrupting the mitochondrial dynamic through the inhibition of fusion and the enhancement of fission. This triggers PINK1-Parkin-mediated mitophagy to eliminate the damaged mitochondria as well as MAVS located on these organelles, thereby inhibiting the IFN I response and ultimately promoting viral replication. PRV infection induces mitophagy to inhibit IFN-I signaling to enhance its own replication. PRV infection damages the structure and function of mitochondria by disrupting the mitochondrial dynamic through the inhibition of fusion and the enhancement of fission. This triggers PINK1-Parkin-mediated mitophagy to eliminate the damaged mitochondria as well as MAVS located on these organelles, thereby inhibiting the IFN I response and ultimately promoting viral replication. Hence, our study reveals a novel mechanism that is used by PRV to antagonize the antiviral host immune response, which will be important to improve our understanding of PRV pathogenesis and provide a theoretical basis for the development of new vaccines and antiviral drugs. Abbreviations BNIP3: BCL2 interacting protein 3; CALCOCO2/NDP52:calcium binding and coiled-coil domain 2; COX-4: cytochrome c oxidase subunit 4; CQ: chloroquine; DRP1:dynamin related protein 1; FUNDC1: FUN14 domain containing 1; IFN-β:interferon beta 1; IFIT1: IFN-stimulated genes tetratricopeptide repeats 1; ISG15: ISG15 ubiquitin like modifier; MAVS: the mitochondrial antiviral signaling protein; Mdivi-1:mitochondrial division inhibitor 1; LAMP1: lysosomal associated membrane protein 1; MFN2: mitofusin 2; MMP: mitochondrial membrane potential; NIX: NIP3-like protein X; OPTN: optineurin; OMM: outer mitochondrial membrane; PARKIN: parkin RBR E3 ubiquitin protein ligase; PINK1: PTEN induced kinase 1; PRV: Pseudorabies virus; RIG-I: RNA sensor RIG-I; SQSTM1/p62: sequestrosome 1; TOM20:translocase of outer mitochondrial membrane 20